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We report herein the successful preparation of a compact, functional CdSe/ZnS core/shell quantum dot
(QD)-DNA conjugate via the highly efficient copper-free “click chemistry” (CFCC) between a dihydro-
lipoic acid-polyethylene glycol-azide (DHLA-PEG-N3) capped QD and a cyclooctyne modified DNA.
This represents an excellent balance between the requirements of high sensing sensitivity, robustness and
specificity for the QD-FRET (Förster resonance energy transfer) based sensor as confirmed by a detailed10
FRET analysis on the QD-DNA conjugate, yielding a relatively short donor-acceptor distance of ~5.8 nm.
We show not only is this CFCC clicked QD-DNA conjugate able to retain the native fluorescence
quantum yield (QY) of the parent DHLA-PEG-N3 capped QD, but also is well-suited for robust, specific
biosensing: it can directly quantitate pM level of both labelled and unlabelled complementary DNA
probes with good SNP (single-nucleotide polymorphism) discrimination ability in complex media, e.g.15
10% human serum via target-binding induced FRET changes between the QD donor and dye accepter.
Further, this sensor has also been successfully exploited for the detection of pM level of a specific protein
target (thrombin) via the encoded anti-thrombin aptamer sequence in the QD-DNA conjugate.
Introduction
The unique, size-dependent, highly stable and bright fluorescence20
of quantum dots (QDs) make them powerful tools in broad ranges
of bio-related applications.1-4 In particular, their broad absorption
and narrow, symmetric emission are extremely well-suited for
Förster resonance energy transfer (FRET) based sensing, because
these spectral characteristics enable a wide selection of excitation25
wavelengths to minimise direct excitation of the acceptor,
reducing background and hence improving sensitivity.1,2 Indeed,
numerous QD-FRET based biosensors have been reported.3,4
Despite these, the sensitivity and specificity of the QD-FRET
based biosensors have largely been limited by challenges in30
preparing compact, functional QD-bioconjugates that are stable
and effectively resisting non-specific adsorption.2-4 For example,
water-soluble QDs prepared by ligand exchange are compact, but
they often show low stability in biologically relevant buffers and
resistance to non-specific adsorption, limiting their sensing35
specificity and robustness.2 Whereas those prepared physical
encapsulations with amphiphilic polymers and/or PEGylated
lipids (where most commercial water-soluble QDs are based) are
stable and can resist non-specific adsorption, but their large sizes
(with hydrodynamic radii often greater than the R0 of most QD-40
dye FRET pairs even prior to bioconjugation)2 can greatly limit
their FRET efficiency (sensitivity). Although FRET efficiency
can be enhanced by increasing the ratio of acceptors on each QD,
such designs are inefficient at low target to QD ratio situations.2
Therefore for biosensing, it is important balance the requirements45
of sensitivity and robustness because they are often incompatible.
In this regard, QDs capped with PEGylated small-molecule
ligands appeared to be highly attractive: they are relatively
compact yet still displaying good stability and, more importantly,
effective resistance to non-specific adsorption of biomolecules.250
Besides surface capping, a robust, efficient QD-bioconjugation
chemistry that can offer high bioactivity without compromising
the QD fluorescence is also important. In this regard, the Cu(I)
catalysed azide-acetylene cycloaddition, best known as the “click
chemistry” (CuCC),5a is highly powerful and versatile: it offers55
exquisite function group selectivity and high yield. It has been
used successfully in preparing a wide range of functional nano-
particle-bioconjugates (e.g. gold, magnetic, silica and polymer
and) for sensing and biomedical applications.5 However, the
CuCC is unsuitable for the QD, because the Cu(I) catalyst used in60
the CuCC can efficiently and irreversibly quench the QD
fluorescence.6 The Cu-free “click chemistry” (CFCC) between
strained cyclooctynes and azide happens rapidly and efficiently,
and moreover, it does not require any Cu catalyst.7 Therefore, the
CFCC appears to be idea for efficient QD-bioconjugation without65
compromising the QD fluorescence.7a Indeed, the CFCC has been
successfully used to make functional QD-protein/small-molecule
conjugates recently for live virus labelling/imaging and intra-
cellular trafficking studies.8 Despite of such developments, the
QDs used in these studies were all capped with polymer based70
ligands (and hence of relatively big sizes) because the QD sizes
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here are less critical for such applications.8 To our knowledge, the
CFCC has yet to be used to develop QD-FRET based biosensors
where a compact size of the QD-bioconjugate is known to be of
critical importance. Herein, we report the successful preparation
of the first compact, functional QD-DNA conjugate via the CFCC5
between a dihydrolipoic acid-polyethylene glycol-azide (DHLA-
PEG-N3) capped CdSe/ZnS core/shell QD and a cyclooctyne
modified DNA, giving a good balance between the requirements
of high sensitivity, specificity and robustness. This is supported
by a FRET analysis showing a relatively short QD-dye distance10
of ~5.8 nm for the QD-DNA FRET system. Moreover, the CFCC
clicked QD-DNA conjugate is found not only retaining the native
fluorescence quantum yield (QY) of the parent QD, but also well-
suited for robust biosensing: it can directly quantitate pM level of
both labelled and unlabelled complementary DNA probes with15
good SNP (single-nucleotide polymorphism) discrimination
ability even in complex media, e.g. 10% human serum, on a
conventional fluorimeter. It can also directly detect pM level of a
specific protein via the encoded DNA aptamer sequence.
Results and discussion20
CFCC based QD-DNA conjugation and sensing principle
Scheme 1. (A) Schematic approach to the Cu-free “clicked” QD-DNA
conjugate. (B) Hybridization of a complementary dye-labelled DNA25
probe to the QD-DNA conjugate leads to QD sensitized dye FRET signal
as readout for labelled DNA detection. (C) Incubation of the QD-double-
stranded (ds)DNA conjugate formed in (B) with a longer, unlabeled DNA
displaces the shorter labelled DNA reporter, reducing the QD to dye
FRET for label-free DNA detection. (D) Incubation of the QD-dsDNA30
conjugate (B) with a target protein that binds to the encoded aptamer
sequence in the QD-dsDNA conjugate displaces the reporter DNA,
leading to reduced QD to dye FRET for label-free protein detection. The
block arrows give the FRET directions.
Scheme 1 shows our approach to the QD-DNA conjugate via the35
CFCC and its use in label- and label-free- detection of DNA and
protein targets via target binding induced changes to the QD
sensitized dye FRET signals. First, a multi-functional ligand,
containing a dihydrolipoic acid (DHLA, for strong QD binding)
head group, a polyethylene glycol moiety of a molecular weight40
of 600 (PEG600, for providing a good water-solubility and
effective resistance to non-specific adsorption of biomolecules)
and a terminal azide group (for efficient DNA conjugation via the
CFCC), DHLA-PEG600-N3, was prepared (see SI for details).9,10
A PEGylated DHLA ligand was used as the QD surface capping45
ligand here because it represented an excellent balance between
the requirements of high stability and resistance to non-specific
adsorption (for robust biosensing) and the structural compactness
(for high sensitivity).2 Then a hydrophobic CdSe/ZnS core/shell
QD (EM ~605 nm, QY ~20%, capped with hydrophobic trioctyl-50
phosphine oxide/trioctylphosphine) was made water-soluble by
ligand exchange with the DHLA-PEG600-N3 in a mixed solvent
of CHCl3/ethanol using our previously established procedures,3l
yielding the QD-DHLA-PEG600-N3 which was readily in polar
solvents. Its fluorescence QY was found to decrease to ~6.0%55
(and hence a decrease of ca 70%), which agreed well with most
other literatures where most hydrophobic CdSe/ZnS core/shell
QDs typically showed a QY decrease of 50-80% following the
ligand exchange and transferred to aqueous media.3,4 A single-
stranded (ss) target DNA encoded with a 29 mer anti-thrombin60
(TB) aptamer sequence with strong affinity for TB (Kd ~0.5 nM,
modified with a C6-amine at 5’, H2N-TBA, see Table 1)11 was
reacted with an N-hydroxysuccinimide (NHS) ester activated
cyclooctyne to yield TBA-cyclooctyne, which was then reacted
with the QD-DHLA-PEG600-N3 in a mixed solvent of ethanol/65
water at a molar ratio of 30:1. This led to the QD-TBA covalent
conjugation via the efficient CFCC approach. Approximately 20
strands of TBAs were found to have conjugated to each QD,
denoted as QD-TBA20 hereafter, this gave a DNA conjugation
efficiency of ~67%. The detailed experimental procedures of the70
ligand synthesis and QD-DNA conjugation are given in the
electronic supporting information (ESI). The QY of the resulting
QD-TBA20 was determined as ~5.9% using Rhodamine 6G in
ethanol as the calibration standard (QY 95%),3b which is
effectively the same as the QD-DHLA-PEG600-N3 (ca. 6.0%).75
Table 1. The DNA sequences and their abbreviations used in this paper.
TBA is modified with C6NH2 at 5’, and all other DNAs are labelled with
an Atto-647N at 3’. The sequences of DNA29, DNA18, DNA15 and
DNA12 are fully complementary to TBA, but DNA12-SM contains a80
single-base mismatch (shown in bold italic). The 29 mer anti-thrombin
aptamer sequence encoded in TBA is shown in italic. DNA29-NL has the
sequence as DNA29 but without the Atto647N label.
DNA code Sequence
TBA 5’-TTAGTCCGTGGTAGGGCAGGTTGGGGTGACT-3’85
DNA29 3’-TCAGGCACCATCCCGTCCAACCCCACTGA-5’
DNA18 3’-AATCAGGCACCATCCCGT-5’
DNA15 3’-AATCAGGCACCATCC-5’
DNA12 3’-TCAGGCACCATC-5’
DNA12-SM 3’-TCAGACACCATC-5’90
DNA-NC 3’-TAGTCC CGATT TCTCACG-5’
The QD-TBA20 was found to be highly soluble and stable in
aqueous media. It showed no change of physical appearance or
fluorescence after being stored in a fridge at 4 oC for over two95
months. More importantly, the QD-TBA20 was found to have
effectively retained the native QY of the parent QD-DHLA-
PEG600-N3. In contrast, conjugation of the H2N-TBA to a water-
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soluble, glutathione capped QD (the same batch of QD, QY =
~18% in water) by using 1-Ethyl-3-[3-dimethylaminopropyl]
carbodiimide (EDC)/NHS mediated covalent coupling resulted in
significantly reduced QY. The fluorescence intensity of former
was ~6.4 times as strong as the later (see ESI, Fig. S1). Moreover,5
the number of TBA strands conjugated to each QD by the CFCC
(20) was also 4 times that of the later (~5). All these demonstrate
that the CFCC based QD-DNA conjugation approach developed
herein is far superior over the EDC/NHS mediated coupling, a
conventional widely used QD-bioconjugation method,3 in terms10
of both DNA conjugation efficiency and ability of maintaining a
high QY of the QD.
FRET analysis of the CFCC clicked QD-DNA conjugate.
Prior to using the CFCC clicked QD-DNA conjugate for sensing,
a FRET analysis on the CFCC clicked QD-DNA conjugate15
hybridised with a complementary strand (DNA29) was carried
out to ensure a relatively small donor-acceptor distance (r) for
high sensitivity. This is because FRET efficiency (E) decreases
dramatically with the increasing r value following the Förster
dipole-dipole interaction formula:20
E = 1/[1 + (r/R0)6] (1)
Where R0 is the Förster radius of the single donor (QD)-single
acceptor (Atto647N) FRET pair here, under which E = 50%. R0
can be estimated from the spectral overlap (I) and the QY of the
QD donor via the following equation:25
ܴ଴ = ൬[ଽ଴଴଴×(௟௡ଵ଴)]௞೛మଵଶ଼గఱ ௡ವరேಲ ܳ ܻ× ܫ൰ଵ ଺ൗ (2)
Where nD is the refractive index of the medium (estimated as 1.4
here); NA is Avogadro’s number (6.02×1023); kp2 is the orientation
factor (2/3 here assuming randomly orientated fluorophores). The
integral of the spectral overlap, I, is defined as:30
ܫ= ∫ ܬ(ߣ)∞଴ = ∫ ܨ஽(ߣ)߳஺(ߣ)∞଴ ߣସ݀ߣ (3)
I is the integral of the donor-acceptor spectral overlap over all
wavelengths λ; FD-corr is the normalized donor emission and A is
the absorption extinction coefficient of the acceptor.
The normalised absorption and emission spectra of the QD and35
Atto647N are shown in ESI, Fig. S1A. A significant overlap
between the QD (donor) emission and Atto647N (acceptor)
absorption is clear, suggesting the two can have efficient FRET.
The donor-acceptor spectra overlap, I, can be calculated from Fig.
S1B, giving a value of 6.68 × 1015 M-1.cm-1.nm4. These combined40
with the QY of the QD (5.9%) and the parameters above, yield a
R0 value of 4.25 nm for the QD-Atto647N FRET pair (at 1:1
molar ratio).
For a single-donor (QD here) simultaneously FRET with n
identical acceptors system, E is given by the following equation:45
E = nR06/[r6 + nR06] (4)
Where the apparent E can be estimated directly from the acceptor
fluorescence enhancement via the following equation:
Apparent E = IA/[IA + ID] (5)
Where IA and ID are the integrated acceptor and donor50
fluorescence intensities, respectively. Here a ratiometric FRET
analysis is used which can be more reliable than those only based
on donor quenching because it can be essentially insensitive to
instrument noise and signal fluctuations, making analysed result
potentially more accurate. Moreover, IA here only comes from the55
QD-sensitised FRET because the acceptor is not directly excited
under our experimental conditions (see next section below) and
any unbound species will be too far away to participate the FRET
process, and hence not interfering with target detection, allowing
highly convenient, separation-free measurement.60
The FRET study was carried out with 2 nM of the QD-TBA20
(2 nM) sample after hybridization with different molar equivalent
of DNA29 (3’-labelled with an Atto647N acceptor, see Table 1).
Hybridization of DNA29 to the QD-TBA20 should bring the
Atto647N acceptor to the close proximity to the QD, leading to65
QD sensitized Atto-647N FRET signal upon excitation of the QD
(Scheme 1B). For Equation (4) to be valid, all DNA29 strands
introduced (and Atto647N labels) should bind to the QD-TBA20.
Hence the longest DNA29 probe which forms the most stable
duplex with the QD-TBA20 was used.70
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Fig. 1. (A) Fluorescence spectra of QD-TBA20 (2 nM) hybridised withdifferent molar equivalent of DNA29 with 7µM His6-Cys peptide. TheDNA29 only curve has a concentration of 60 nM. (B) A plot of the75 apparent E as a function of DNA29/QD molar ratio, data were fittedusing equation (4), yielding a r value of 5.82±0.01 nm.
Fig. 1A clearly shows that with the increasing molar ratio of
the DNA29:QD-TBA20, the QD fluorescence is quenched while80
the Atto647N FRET signal is increased progressively, suggesting
efficient FRET between the QD and Atto647N dye. Moreover,
the resulting E and DNA29/QD molar ratio can be fitted well by
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the single-QD donor FRET with multiple identical acceptor
model (R2 = 0.99) with a relatively short donor-acceptor distance
r of 5.82±0.01 nm. This result confirms that the CFCC clicked
QD-DNA conjugate FRET system is indeed compact, and
moreover, all Atto647N labels on the DNA29 strands are bound5
to the QD at an identical spatial separation (the same QD-dye
distance r).
Detection of DNA29 using the CFCC clicked QD-TBA20.
10
The sensitivity of the QD-TBA20 based FRET sensor in detecting
complementary DNA probes was further evaluated by using
DNA29. Hybridization of DNA29 to the QD-TBA20 should bring
the Atto647N dye (acting as the FRET acceptor) to the close
proximity to the QD, leading to QD sensitized Atto647N FRET15
signal upon excitation of the QD. A significant advantage of
FRET based signal readout over other approaches (e.g. donor
quenching or life time change) is its ratiometric signal, which can
be effectively insensitive to signal fluctuation and instrument
noise, allowing for more reliable, accurate detection.2 Moreover,20
since FRET only happens over short distances (ca. < 10 nm), any
free, unbound species will be too far to FRET with the QD donor
and hence undetected, allowing for convenient probe detection to
be carried out in a separation-free format.2,3n Interestingly, the
QD-TBA20 (CQD = 2 nM) fluorescence in PBS (10 mM sodium25
phosphate, 150 mM NaCl, pH 7.40) was found to be enhanced
significantly after treatments with a cysteine-histidine6 short
peptide and/or bovine serum albumin (BSA, see ESI, Fig. S2A).
Presumably because these molecules can bind or adsorb onto the
QD-TBA20 to enhance the QD fluorescence QY as reported30
previously.3a They may also adsorb onto sample tubes to reduce
the non-specific adsorption and/or salt-induced aggregation of the
QD. Moreover, the added peptide/BSA was also found to
improve the FRET efficiency of the QD-TBA/DNA29 system
considerably (see ESI, Fig. S2B), and the effect became saturated35
at ~7 M. With the peptide/BSA being added, the hybridized
QD-TBA20/DNA29 FRET system was found to be highly stable,
no significant change of the QD fluorescence or Atto647N FRET
signals were observed after being stored for 18 hrs in PBS (see
ESI, Fig. S3). This is important for biosensing, allowing the40
experiments to be carried out at ease without the need to worry
about the stability of the sensor (from our own experience, most
small-molecule ligands capped QDs, including glutathione, 3-
mercaptopropinoic acid (MPA) and DHLA, showed rather
limited stability in PBS, and therefore all sensing measurements45
should be performed within 1 h after target addition to avoid
significant decrease of the QD fluorescence).3l,3m,3n,4d,4e All
subsequent sensing experiments were carried out with 7 M
added peptide/BSA on a conventional fluorimeter with a low QD
concentration of 2 nM.50
Fig. 2. (A) Fluorescence spectra of the QD-TBA20 (CQD = 2 nM) after hybridization with different amounts of DNA29 for 2 hrs in PBS excited at 450 nm,
the abs minimum of Atto647N. (B) A plot of the integrated donor/accepter fluorescence ratio, IDye/IQD, as a function of [DNA29]. The data were fitted to a
two-stage linear relationship with fitting parameters of y = -0.539 + 0.1121x, R2 = 0.9978 over 10-40 nM, and y = -0.000395 + 0.0354x, R2 = 0.9947 over
0-5 nM (shown in the inset), which the detection limit based on. (C) Plot of the IDye/IQD ratios as a function of concentration for different length55
complementary DNA probes. (D) The IDye/IQD ratios for different length DNA probes at 40 nM.
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Fig. 2A shows that in general the QD fluorescence (peaking at
~605 nm) was quenched progressively together with a concurrent
simultaneous significant increase of the Atto647N FRET signal
(peaking at ~665 nm) with the increasing DNA29 concentration,
[DNA29], suggesting efficient QD-sensitised dye FRET from5
hybridisation of the DNA29 to QD-TBA20. A careful examination
of the Atto647N emission spectra over 640-700 nm range
revealed that the Atto647N emission obtained from direct
excitation of 60 nM DNA29 was actually weaker than that of the
QD-sensitized FRET signal for 0.25 nM DNA29 (see ESI, Fig.10
S4), suggesting the QD sensitized FRET is at least 240 times as
efficient as direct excitation. To our knowledge, this is the highest
ratio of FRET-sensitized signal over that of direct excitation for
the QD-FRET systems reported so far (most literature ratios are
typically ranged from ~2.5-40).2,3 This is presumably because EX15
= 450 nm, corresponding to the abs minimum of the Atto647N,
was used here to minimise the direct excitation of the Atto647N
acceptor. Moreover, the CFCC conjugated QD-TBA20 here
retained a much higher QY of the QD than those prepared via the
EDC/NHS coupling (see ESI, Fig. S1), as a result, the sensing20
experiments were able to be performed at 2 nM QD, ~10-100 fold
lower than those reported previously.2,3 Such a high FRET-
sensitised signal over direct excitation background is highly
advantageous for biosensing, which can effectively eliminate the
need of background correction from direct acceptor excitation,25
making data analysis easy and straightforward.
Despite the QD fluorescence did not always follow a simple
trend of progressive quenching with the increasing [DNA29],
especially at low [DNA29] shown in Fig. 2A, possibly due to a
slight increase of the QD QY as DNA29 was hybridized, this had30
no impact on the ratiometric based data analysis employed here.
In fact, the ratio of integrated fluorescence intensity between the
acceptor and donor, IDye/IQD (see ESI for detailed calculation
method)3l displayed a two-stage linear dependence with the
increasing [DNA29]: a slow increasing phase over low [DNA29]35
(0-5 nM, slope: 0.0353 nM-1, R2 = 0.9947) and a more rapid
phase at higher concentrations (10-40 nM, slope: 0.1121 nM-1,
R2=0.9978, Fig. 2B). As [DNA29] was increased to above 40
nM, the IDye/IQD value showed little further increase, suggesting
the hybridization reached saturation. Thereafter, any extra added40
DNA29 strands were unable to hybridize to the QD-TBA20 and
would remain free. Since FRET only takes place over short
distances (ca. < 10 nm), such free DNA29 strands are unable to
participate the FRET process and hence undetected. Note here
that 40 nM corresponds to the total [TBA] in the 2 nM QD-45
TBA20 conjugate, suggesting that all TBAs conjugated to the QD
are functional and available for hybridization. The detection limit
(DL) for DNA29, based on 3 times the standard deviations/slope
of linear calibration over the lower concentration range
(3/slope) is estimated as ~91 pM,3h making it one of the most50
sensitive QD-FRET based sensors for direct DNA quantification
without probe pre-amplification using conventional fluorescence
spectroscopy (see Table 2). Moreover, this level of sensitivity is
also comparable or better than many other sensitive direct DNA
detection methods without probe pre-amplification, such as the55
optimised, sensitive microcantilever sensor (~10 pM),12b electro-
chemical detection (10 pM),12c surface plasmon resonance (SPR,
10 nM)12d and quartz crystal microbalance (QCM, 10 nM)12e
detection (see Table 2 for details).
60
Table 2. Comparison of the sensitivity and specificity of some QD-FRET and other direct DNA detection techniques without probe amplification.
Detection System Target/length Specificity SNP DR LOD (nM) Ref
QD-BRET DNA/22 mer ? ? 20 [3o]
QD-FRET DNA/19 mer < 2 no 40 (1 µM QD) [3g]
QD-FRET DNA/24 mer < 2 no 12 (0.06 µM QD) [3g]65
QD-FRET DNA/25 mer ~3 no 200 [3p]
QD-FRET DNA/18-32 mer 2-3 no ~5 [3q]
QD-FRET DNA/30 mer 34 no 0.5 [3m]
QD-FRET DNA/15 mer ? no 0.4 [3r]
QD-FRET DNA/12-29 mer 816 3.3 (12 mer) 0.091 (29 mer) This work70
Microcantilever DNA/12 mer ? ? 75 [12a]
Microcantilever DNA/12 mer ~3 ? ~0.010 [12b]
Electrochemical DNA/24 mer ? ? 0.01 [12c]
Electrochemical DNA/34 mer yes 1.5-2.0 0.05 [12d]
Direct SPR DNA/16mer ? ? 10 [12e]75
Direct QCM DNA/509 mer ? ? 10 [12f]
BRET: bioluminescence resonance energy transfer; LOD: Limit of detection; Specificity: FRET ratio between the full- and non-complementary DNA
probes; SNP DR: SNP discrimination ratio.
Theoretically, a linear correlation between the IDye/IQD and80
probe concentration, [DNA29], is expected if all introduced DNA
probes are hybridized to the QD-TBA20 at identical position (the
same QD-dye distance, r).13 The excellent linear relationship
observed here clearly confirmed that all DNA29 strands were
hybridized to the QD at identical spatial separations between the85
QD donor and dye acceptor. This result also agrees well with the
earlier FRET analysis where E can be fitted very well (R2 =
0.991) by the single-donor with multiple identical acceptors
FRET interaction model.2 The two-stage linear dependences
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observed here may indicate two different phases of DNA
hybridization: the slower increase over 0-5 nM range is likely due
to incomplete hybridization of DNA29 to the QD-TBA20, arising
presumably from the low, sub-Kd levels of [DNA29]; whereas the
faster increase over 10-40 nM range may be attributed to more5
effective, complete binding of the introduced DNA29 to the QD-
TBA20 under such conditions. Given that Kd values of 17, 19 and
41 nM have been reported for a 25,14a 20,14b and 1212a mer
dsDNAs, respectively, we believe such explanations here are
highly plausible.10
The CFCC clicked QD-DNA FRET sensor was found to be
highly specific: incubation of the QD-TBA20 with a non-
complementary probe (DNA-NC, also 3’-Atto647N labelled, see
Table 1) under identical conditions (with 10 M added BSA)
produced effectively non-detectable FRET. The IDye/IQD ratios for15
the DNA29 and DNA-NC (both at 30 nM) were determined as
2.563 and 0.00314, respectively, yielding an outstanding signal
discrimination ratio of 816 between the full- and non- comple-
mentary DNA probes (see ESI, Fig. S6). The discrimination ratio
here is 24-400 folds higher than previously reported QD-FRET20
based DNA sensors (see Table 2), demonstrating an excellent
DNA sensing specificity. Moreover, the QD-FRET based DNA
sensor was highly robust, it worked pretty well even in clinically
relevant media, e.g. 10% human serum (see ESI, Fig. S7). It
should be noted that despite numerous QD-FRET based DNA25
sensors have been reported in literature, few have demonstrated
working function in serum, one of the most frequently used
clinical media. These results clearly demonstrated an excellent
sensing specificity and robustness of the CFCC clicked QD-DNA
sensor, which we attribute to the excellent stability, and more30
importantly, the outstanding resistance toward non-specific
adsorption of biomolecules afforded by the PEGylated capping
ligands on the QD surface.9,10
Detection of different length DNA probes and SNP (single-
nucleotide polymorphism) discrimination35
Besides offering high discrimination between complementary and
non-complementary DNA probes, the CFCC clicked QD-DNA
sensor can effectively discriminate complementary DNA probes
of different lengths. As shown in Fig. 2C, although the IDye/IQD
ratios increased with the increasing concentration for all probes,40
the rates of increase were significantly different, with DNA29
being the fastest while DNA12-SM being the slowest. A general
trend here is that the IDye/IQD increase rate showed a positive
correlation to the length of the DNA probe, e.g. DNA29 >
DNA18 > DNA15 > DNA12 >DNA12-SM. Moreover, DNA1845
also showed a two-stage IDye/IQD–[DNA] linear increase similar to
that for DNA29, while for DNA15 and DNA12, this became
much less clear, and DNA12-SM effectively displayed a single
linear dependence. Such differences may reflect their different
Kds of the different length probes toward the common TBA50
target: only those with Kds that span across the [DNA] range
studied here may display two-stage dependences.
The slopes of the rapid increasing IDye/IQD phase (over 10-40
nM range) were found to be 0.112, 0.091, 0.062, 0.036 and 0.011
nM-1 for DNA29, DNA18, DNA15, DNA12 and DNA12-SM,55
respectively. Therefore the slope of IDye/IQD increase rate for the
DNA29 is ~ 3 times that of DNA12; while that for DNA12 is a
further ~3.3 times that of DNA12-SM, the same length (12 mer)
probe containing just a single base mismatch to TBA, equivalent
to a single nucleotide polymorphism (SNP). The CFCC clicked60
QD-DNA sensor can therefore offer a SNP discrimination ratio of
~3.3 for the 12 mer DNA probes. Similar levels of probe length
dependences and SNP discrimination ratio (ca. > 3 between
DNA12 and DNA12-SM) were also obtained from the IDye/IQD
ratios at 40 nM probe concentration (Fig. 2D). More interestingly,65
the discrimination between DNA12 and DNA12-SM was found
to be unaffected by the presence of complex media, such as 10%
human serum. In fact, the discrimination ratio actually increased
to 6.1 (against ~3 in PBS, see ESI, Fig. S8), demonstrating a good
potential for SNP based clinical diagnosis. It should be noted that70
despite several QD-FRET based DNA sensors have been reported
in literature, most of which displayed rather low discrimination
ratios between full- and non- complementary DNA probes, few
have displayed SNP discrimination ability (see Table 2). Since
SNPs are known to be closely associated with a number of75
important human diseases, such as cancer, neurodegenerative
diseases and diabetes etc,15 the excellent specificity, sensitivity
and robust SNP discrimination ability in complex media may
make the CFCC clicked QD-DNA sensor potentially suitable for
clinical applications.80
Detection of unlabelled DNA probe
85
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105
Fig. 3. (A) Typical fluorescence spectra of QD-TBA20 (2 nM) pre-
hybridized to DNA12-SM (60 nM) after addition of different [DNA29-
NF] for 2 hrs. (B) A plot of the corresponding fluorescence intensity ratio
at 605 and 665 nm (I605/I665) as a function of [DNA29-NF], inset shows110
response curve at the sub-nM range.
The ability of detecting unlabeled DNA probes is more useful
for potential clinical applications, avoiding the need of the probe
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labelling step which can be complex, expensive and sometimes
even impossible. In this regard, a new DNA displacement assay is
developed here: a longer unlabeled probe (e.g. DNA29-NL, with
the same sequence as DNA29 but without the Atto647N label)
that forms more stable duplex with TBA can effectively displace5
a shorter labelled DNA (e.g. DNA12-SM, acting as a FRET
reporter) pre-hybridized to the QD-TBA20, leading to a decreased
FRET as the unlabelled probe readout signal (Scheme 1C).
Fig. 3 reveals that this is indeed feasible: where the Atto647N
FRET signal at ~665 nm was almost diminished accompanied10
with a concurrent significant recovery of the QD fluorescence at
605 nm as the [DNA29-NL] was increased, suggesting a
successful displacement of the DNA12-SM reporter strand by the
DNA29-NL, leading to a significant increase (~21 fold) of the
I605/I665 ratio (from 1.32± 0.06 to 28.6 ± 2.2 as the [DNA29-NL]15
increased from 0 at 100 nM, see Fig. 3B). Interestingly, replacing
the DNA12-SM with DNA12 as the FRET reporter strand led to a
much smaller increase of the I605/I665 ratio under identical
conditions (from 0.66 ± 0.02 to 3.48 ± 0.09, an increase of ~5.3
fold, see ESI, Fig. S9 for details), suggesting that a high stability20
difference between the reporter and probe DNAs for the common
target is key to achieve efficient reporter strand displacement and
hence greatly increased I605/I665 ratio. The I605/I665 response curve
as a function of [DNA29-NL] was found to be non-linear (Fig.
3B), where 500 pM [DNA29-NL] produced a signal consistently25
above the background (Fig. 3B inset), suggesting this sensor can
readily detect 500 pM DNA29-NL without probe amplification.
Therefore this signal-on DNA sensing approach developed here
can readily detect ~500 pM unlabelled DNA probes together with
a maximum ratiometric signal enhancement of ~ 21 fold, which is30
already competitive against some other more established DNA
sensing approaches, such as molecular beacons (ca. 10-20 fold
signal enhancement with single-quenchers and nM
sensitivity)11b,11c and a recently optimised electrochemical DNA
sensor (ca. 8 fold).12d An advantage of our approach here is its35
ratiometric signal, which can be effectively insensitive to
instrument noise and signal fluctuation, allowing more reliable
target detection. In addition, the DNA displacement assay was
found to work equally efficient in complex media, such as PBS
with large excess of BSA (10 M) and in 10% human serum,40
suggesting it may have good potential for clinical application.
Detection of unlabelled protein
The CFCC clicked QD-TBA20 can be readily extended for
label-free protein sensing via the anti-thrombin DNA aptamer
sequence encoded within the TBA sequence: where the formation45
of thrombin (TB)/TBA complex can effectively displace the pre-
hybridised reporter DNA12-SM, leading to FRET decrease (and
hence an increase of the I605/I665 ratio, see Scheme 1D). Figure
S10 (ESI) revealed this was indeed true, where the Atto647N
FRET signal gradually was decreased while the QD fluorescence50
was increased concurrently as the target [TB] was increased,
leading to increased I605/I665 ratio (see Fig. 4). The maximum
I605/I665 ratio obtained at 100 nM TB here (~3.1) was not as high
as that obtained in DNA29-NF detection (~29), suggesting that
the TB binding here is less efficient in displacing the DNA12-SM55
reporter strands from the QD-TBA20 conjugate as compared to
DNA29-NF. Given that the binding affinity between the 29 mer
anti-TB aptamer and TB (Kd ~0.5 nM)11a is as strong as that of
the TBA/DNA29 duplex (~0.3 nM estimated above) here, the
relatively low efficiency in displacing the reporter strands60
observed for TB here is therefore attributed to the significantly
greater size of the TB-aptamer complex as compared to
TBA/DNA29 duplex, leading to steric hindrance and reduced
accessibility for TB binding on the QD-DNA conjugate,
especially under high [TB] situations. Similar to the DNA29-NL65
based displacement assay above, a non-linear response curve
between the I605/I665 signal and [TB] was also observed (Fig. 4).
Moreover, the amplified response curve over 0-2 nM [TB] range
revealed that 500 pM [TB] produced a signal consistently above
the background (Fig. 4, inset), suggesting the CFCC clicked QD-70
DNA aptamer sensor can detect 500 pM TB directly without
target pre-amplification. This sensitivity achieved here is among
the most sensitive QD-FRET based label-free TB sensors using
direct target detection without pre-amplification (see ESI, Table
S1). Moreover, this sensitivity is also comparable to other more75
established electrochemical sensing method for TB detection
(with a detection limit of ~ 1 nM).12g
Fig. 4. Label-free detection of thrombin using the CFCC clicked QD-
DNA aptamer sensor using 2 nM QD-TBA20 pre-hybridized to DNA12-
SM (60 nM) in PBS containing 20 M BSA. A typical calibration curve80
showing the I605/I665 ratio as a function of thrombin concentration [TB]
(inset: the response over 0-2 nM of [TB]).
Conclusion
In summary, we have successfully developed a reliable CFCC85
approach for the preparation of a compact, stable QD-DNA/
aptamer conjugate that can retain the native fluorescence QY of
the parent QD. The resulting QD-DNA conjugate has been used
for robust, sensitive and ratiometric quantitation of specific DNA
probes directly with pM sensitivity even in complex media, such90
as 10% human serum. This QD-DNA FRET sensor has offered
an excellent signal discrimination (> 800 fold) between the full-
and non-complementary DNA probes, which is the highest for the
QD-FRET based sensors. Moreover, it can discriminate between
the perfect-match and SNP targets in 10% serum. The sensor has95
also been exploited for sensitive label-free detection of pM level
of thrombin via the anti-thrombin aptamer sequence encoded in
the QD-DNA conjugate. This QD-DNA/aptamer sensor can be
readily extended for detection of other DNA and protein targets
by clicking other specific DNA/aptamer sequences against such100
targets.16 Given its high stability, specificity, robustness and
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sensitivity, the CFCC clicked QD-DNA/aptamer sensor
sensitivity, the CFCC clicked QD-DNA/aptamer sensor appears
to have good potential in a wide range of biosensing and
diagnostic applications.
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